Glenmark Life Sciences
₹750.5
-76 (-9.2%)
25 April, 2024 18:08 BSE: 543322
NSE: GLSISIN: INE03Q201024
Start SIP in Glenmark Life Sciences
Start SIPGlenmark Life Sciences Performance
Day Range
- Low 744
- High 832
52 Week Range
- Low 456
- High 906
- Open Price827
- Previous Close827
- Volume589960
Glenmark Life Sciences Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 573 | 595 | 578 | 621 |
Operating Expenses Qtr Cr | 400 | 428 | 385 | 415 |
Operating Profit Qtr Cr | 173 | 167 | 193 | 206 |
Depreciation Qtr Cr | 13 | 13 | 13 | 12 |
Interest Qtr Cr | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 42 | 40 | 47 | 51 |
Net Profit Qtr Cr | 119 | 119 | 135 | 146 |
Glenmark Life Sciences Technicals
EMA & SMA
Current Price
₹750.5
-76 (-9.2%)
- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹804.19
- 50 Day
- ₹794.47
- 100 Day
- ₹764.59
- 200 Day
- ₹703.10
- 20 Day
- ₹800.09
- 50 Day
- ₹810.09
- 100 Day
- ₹766.08
- 200 Day
- ₹696.62
Glenmark Life Sciences Resistance and Support
PIVOT
₹829.09
Resistance | |
---|---|
First Resistance | 836.02 |
Second Resistance | 845.53 |
Third Resistance | 852.47 |
RSI | 58.61 |
MFI | 70.84 |
MACD Single Line | 5.06 |
MACD | 9.30 |
Support | |
---|---|
First Resistance | 819.57 |
Second Resistance | 812.63 |
Third Resistance | 803.12 |
Glenmark Life Sciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 29,579 | 1,462,090 | 49.43 |
Week | 80,382 | 4,261,843 | 53.02 |
1 Month | 87,321 | 5,215,712 | 59.73 |
6 Month | 175,060 | 10,927,268 | 62.42 |
Glenmark Life Sciences Result Highlights
Glenmark Life Sciences Synopsis
NSE-Medical-Ethical Drugs
Glenmark Life Scienc belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 2161.22 Cr. and Equity Capital is Rs. 24.51 Cr. for the Year ended 31/03/2023. Glenmark Life Sciences Ltd. is a Public Limited Listed company incorporated on 23/06/2011 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74900PN2011PLC139963 and registration number is 139963.Market Cap | 9,496 |
Sales | 2,368 |
Shares in Float | 2.08 |
No of funds | 88 |
Yield | 2.72 |
Book Value | 4.74 |
U/D Vol ratio | 0.8 |
LTDebt / Equity | |
Alpha | 0.13 |
Beta | 0.92 |
Glenmark Life Sciences
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 82.85% | 82.85% | 82.85% | 82.85% |
Mutual Funds | 0.93% | 0.59% | 0.38% | 0.52% |
Insurance Companies | 0.15% | |||
Foreign Portfolio Investors | 5.01% | 4.57% | 4.39% | 3.27% |
Financial Institutions/ Banks | ||||
Individual Investors | 9.09% | 9.2% | 9.21% | 10.02% |
Others | 2.12% | 2.79% | 3.02% | 3.34% |
Glenmark Life Sciences Management
Name | Designation |
---|---|
Mr. Glenn Saldanha | Chairman & Non-Exe.Director |
Dr. Yasir Rawjee | Managing Director & CEO |
Mr. Vinod Naik | Executive Director |
Mr. V S Mani | Non Executive Director |
Mr. Sridhar Gorthi | Independent Director |
Mrs. Manju Agarwal | Independent Director |
Mr. Taruvai Laxminarayanan Easwar | Independent Director |
Ms. Gita Nayyar | Independent Director |
Glenmark Life Sciences Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Glenmark Life Sciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-04-25 | Audited Results | |
2024-01-23 | Quarterly Results | |
2023-10-20 | Quarterly Results | |
2023-10-09 | Interim Dividend | |
2023-07-21 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-10-17 | INTERIM | Rs.22.50 per share(1125%)Interim Dividend |
2023-03-24 | INTERIM | Rs.21.00 per share(1050%)Interim Dividend |
2021-11-23 | INTERIM | Rs.10.50 per share(525%)Interim Dividend |
Glenmark Life Sciences FAQs
What is Share Price of Glenmark Life Sciences ?
Glenmark Life Sciences share price is ₹750 As on 25 April, 2024 | 17:54
What is the Market Cap of Glenmark Life Sciences ?
The Market Cap of Glenmark Life Sciences is ₹9195.7 Cr As on 25 April, 2024 | 17:54
What is the P/E ratio of Glenmark Life Sciences ?
The P/E ratio of Glenmark Life Sciences is 17.7 As on 25 April, 2024 | 17:54
What is the PB ratio of Glenmark Life Sciences ?
The PB ratio of Glenmark Life Sciences is 4.3 As on 25 April, 2024 | 17:54